Nanogen's Q2 Loss Widens 45 Percent Though Product Sales Swell 273 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Nanogen said today that second-quarter revenues more than doubled as a result of products gained from its acquisitions, but losses widened 45 percent in integration costs.
 
Receipts for the second quarter more than doubled to $6.3 million from $3.1 million in the same quarter last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.